Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
38.67
-0.05 (-0.13%)
At close: Aug 15, 2025, 4:00 PM
39.20
+0.53 (1.37%)
After-hours: Aug 15, 2025, 7:57 PM EDT

Cytokinetics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Cash & Equivalents
74.9494.86113.0265.58112.6782.99
Upgrade
Short-Term Investments
783.2981.16501.8717358.97381.08
Upgrade
Cash & Short-Term Investments
858.141,076614.82782.58471.64464.06
Upgrade
Cash Growth
-18.80%75.01%-21.44%65.93%1.63%106.15%
Upgrade
Accounts Receivable
8.4116.651.280.1556.826.92
Upgrade
Receivables
8.4116.651.280.1556.826.92
Upgrade
Prepaid Expenses
2015.2811.9412.467.223.24
Upgrade
Total Current Assets
886.541,108628.05795.19535.67474.22
Upgrade
Property, Plant & Equipment
146.34140.97147.74163.19146.4116.27
Upgrade
Long-Term Investments
178.2145.0640.5346.71152.0536.95
Upgrade
Other Long-Term Assets
14.557.7189.697.196.36
Upgrade
Total Assets
1,2261,402824.321,015841.32533.8
Upgrade
Accounts Payable
16.2320.3721.5125.6121.098.05
Upgrade
Accrued Expenses
52.3255.3242.6444.134.3719.32
Upgrade
Short-Term Debt
-11.3----
Upgrade
Current Portion of Long-Term Debt
14.411.5210.080.96--
Upgrade
Current Portion of Leases
19.5919.1817.8912.8314.862.79
Upgrade
Current Unearned Revenue
1.3452.37----
Upgrade
Other Current Liabilities
27.199.6110.561.121.541.05
Upgrade
Total Current Liabilities
131.06179.67102.6884.6271.8631.2
Upgrade
Long-Term Debt
846.75768.6607.37609.62142.84135.71
Upgrade
Long-Term Leases
111.03112.58120.43126.9112.230.44
Upgrade
Long-Term Unearned Revenue
489.5462.19379.98300.5266.07253.07
Upgrade
Other Long-Term Liabilities
16.02140.191.044.46-
Upgrade
Total Liabilities
1,5941,5371,2111,123597.46420.42
Upgrade
Common Stock
0.120.120.10.090.080.07
Upgrade
Additional Paid-In Capital
2,6292,5641,7261,4821,4521,105
Upgrade
Retained Earnings
-2,998-2,702-2,112-1,586-1,208-992.31
Upgrade
Comprehensive Income & Other
-0.162.4-0.01-3.59-0.870.15
Upgrade
Shareholders' Equity
-368.72-135.37-386.32-107.9243.86113.38
Upgrade
Total Liabilities & Equity
1,2261,402824.321,015841.32533.8
Upgrade
Total Debt
991.76923.18755.77750.3269.93138.94
Upgrade
Net Cash (Debt)
-133.62152.83-140.9532.28201.71325.12
Upgrade
Net Cash Growth
----84.00%-37.96%265.13%
Upgrade
Net Cash Per Share
-1.131.36-1.460.362.625.04
Upgrade
Filing Date Shares Outstanding
119.66118.4110395.1684.8671.11
Upgrade
Total Common Shares Outstanding
119.6118.21101.6494.8384.871.02
Upgrade
Working Capital
755.48928.27525.37710.57463.81443.02
Upgrade
Book Value Per Share
-3.08-1.15-3.80-1.142.881.60
Upgrade
Tangible Book Value
-368.72-135.37-386.32-107.9243.86113.38
Upgrade
Tangible Book Value Per Share
-3.08-1.15-3.80-1.142.881.60
Upgrade
Machinery
-30.8228.1628.4527.4822.99
Upgrade
Construction In Progress
-4.070.220.740.229.13
Upgrade
Leasehold Improvements
-66.8766.8765.9160.345.87
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q